DEFECTS IN THE HSD11 GENE ENCODING 11-BETA-HYDROXYSTEROID DEHYDROGENASE ARE NOT FOUND IN PATIENTS WITH APPARENT MINERALOCORTICOID EXCESS OR11-OXOREDUCTASE DEFICIENCY
H. Nikkila et al., DEFECTS IN THE HSD11 GENE ENCODING 11-BETA-HYDROXYSTEROID DEHYDROGENASE ARE NOT FOUND IN PATIENTS WITH APPARENT MINERALOCORTICOID EXCESS OR11-OXOREDUCTASE DEFICIENCY, The Journal of clinical endocrinology and metabolism, 77(3), 1993, pp. 687-691
The syndrome of apparent mineralocorticoid excess (AME) is a form of l
ow renin hypertension that is thought to be caused by congenital defic
iency of 11beta-hydroxysteroid dehydrogenase (11HSD) activity. This en
zyme converts cortisol to cortisone and apparently prevents cortisol f
rom acting as a ligand for the mineralocorticoid (type 1) receptor. It
also catalyzes the reverse oxoreductase (cortisone to cortisol) react
ion. Four patients with AME and the parents of the first patient descr
ibed (now deceased) were analyzed for mutations in the cloned HSD11 ge
ne encoding an 11HSD enzyme. A patient with suspected cortisone reduct
ase deficiency was also studied. No gross deletions or rearrangements
in the HSD11 gene were apparent on hybridizations of blots of genomic
DNA. Direct sequencing of polymerase chain reaction-amplified fragment
s corresponding to the coding sequences, intronexon junctions, and pro
ximal untranslated regions of this gene revealed no mutations. AME may
involve mutations in a gene for another enzyme with 11HSD activity or
perhaps another cortisol-metabolizing enzyme.